EUDRAC AG is a European specialised regulatory affairs and pharmacovigilance consultancy that supports clients through product development, marketing-authorisation applications (MAA), market launch and post-authorisation activities across EU countries. Services include dossier writing and submission, pharmacovigilance services, audit/inspection support and regulatory advice for medical devices and nutritional supplements.
AI-generated
Offering
Products & services
Industry:Management Consulting
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Regulatory Affairs and Pharmacovigilance Consulting
Regulatory affairs and pharmacovigilance consultancy for medicinal products, supporting development, registration, market launch and post-approval activities in EU countries.
Marketing Authorisation Applications (MAA)
Support throughout the entire MAA process, including preparation, review and submission of the required modules, as well as guidance through the assessments up to approval.
Scientific Dossier Writing
Scientific dossiers for medicinal products, including information on safety, efficacy, quality and manufacturing; preparation in CTD format for central, national, MRP and DCP procedures.
Pharmacovigilance Services
Pre- and post-marketing pharmacovigilance, including intelligence reviews, training and support for audits and inspections to ensure regulatory compliance.
Variations, Renewals, MA transfer
Post-authorisation support for medicinal products: variations, renewals and transfer of the marketing authorisation with regulatorily controlled procedures.
Knowledge
No knowledge articles yet
Once EUDRAC AG has claimed this profile, we'll publish editorial articles and case studies here together.